73 related articles for article (PubMed ID: 25512414)
1. Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patients.
Wong G; Farkas A; Sussman R; Daroczi G; Hope WW; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2015 Mar; 59(3):1411-7. PubMed ID: 25512414
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacokinetics software for therapeutic drug monitoring of piperacillin in patients with severe infections.
Rodríguez-Báez AS; Jiménez-Meseguer M; Milán-Segovia RDC; Romano-Moreno S; Barcia E; Ortiz-Álvarez A; García-Díaz B; Medellín-Garibay SE
Eur J Hosp Pharm; 2024 Apr; 31(3):201-206. PubMed ID: 36126967
[TBL] [Abstract][Full Text] [Related]
3. Multistate modeling for survival analysis in critically ill patients treated with meropenem.
Peng Y; Minichmayr IK; Liu H; Xie F; Friberg LE
CPT Pharmacometrics Syst Pharmacol; 2024 Feb; 13(2):222-233. PubMed ID: 37881115
[TBL] [Abstract][Full Text] [Related]
4. Derivation and Validation of a New Equation for Estimating Free Valproate Concentration in Critically Ill Adult Patients.
Liu JT; Brown CS; Mara KC; Riker RR; Rabinstein AA; Fraser GL; May TL; Armstrong KJ; Seder DB; Gagnon DJ
Crit Care Explor; 2023 Oct; 5(10):e0987. PubMed ID: 37868026
[TBL] [Abstract][Full Text] [Related]
5. Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.
Chai MG; Tu Q; Cotta MO; Bauer MJ; Balch R; Okafor C; Comans T; Kruger P; Meyer J; Shekar K; Brady K; Fourie C; Sharp N; Vlad L; Whiley D; Ungerer JPJ; Mcwhinney BC; Farkas A; Paterson DL; Clark JE; Hajkowicz K; Raman S; Bialasiewicz S; Lipman J; Forde BM; Harris PNA; Schlapbach LJ; Coin L; Roberts JA; Irwin AD
Intensive Care Med; 2024 May; 50(5):810. PubMed ID: 38563901
[No Abstract] [Full Text] [Related]
6. Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.
Abdul-Aziz MH; Lipman J; Mouton JW; Hope WW; Roberts JA
Semin Respir Crit Care Med; 2015 Feb; 36(1):136-53. PubMed ID: 25643277
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.
Hall Snyder AD; Vidaillac C; Rose W; McRoberts JP; Rybak MJ
Infect Dis Ther; 2014 Dec; 4(1):51-65. PubMed ID: 25519162
[TBL] [Abstract][Full Text] [Related]
8. Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial.
Sime FB; Roberts MS; Tiong IS; Gardner JH; Lehman S; Peake SL; Hahn U; Warner MS; Roberts JA
J Antimicrob Chemother; 2015 Aug; 70(8):2369-75. PubMed ID: 25953805
[TBL] [Abstract][Full Text] [Related]
9. Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study.
Huttner A; Von Dach E; Renzoni A; Huttner BD; Affaticati M; Pagani L; Daali Y; Pugin J; Karmime A; Fathi M; Lew D; Harbarth S
Int J Antimicrob Agents; 2015 Apr; 45(4):385-92. PubMed ID: 25656151
[TBL] [Abstract][Full Text] [Related]
10. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study.
Shekar K; Fraser JF; Taccone FS; Welch S; Wallis SC; Mullany DV; Lipman J; Roberts JA;
Crit Care; 2014 Dec; 18(6):565. PubMed ID: 25636084
[TBL] [Abstract][Full Text] [Related]
11. Implementing extended-infusion cefepime as standard of care in a children's hospital: a prospective descriptive study.
Nichols KR; Karmire LC; Cox EG; Kays MB; Knoderer CA
Ann Pharmacother; 2015 Apr; 49(4):419-26. PubMed ID: 25614528
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the association between an antimicrobial stewardship score and antimicrobial usage.
Pakyz AL; Moczygemba LR; Wang H; Stevens MP; Edmond MB
J Antimicrob Chemother; 2015 May; 70(5):1588-91. PubMed ID: 25614043
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.
Wicha SG; Haak T; Zink K; Kees F; Kloft C; Kees MG
J Clin Pharmacol; 2015 Jun; 55(6):639-46. PubMed ID: 25600294
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
Marini BL; Hough SM; Gregg KS; Abu-Seir H; Nagel JL
Support Care Cancer; 2015 Aug; 23(8):2287-95. PubMed ID: 25576429
[TBL] [Abstract][Full Text] [Related]
15. A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis.
Nguyen AD; Heil EL; Patel NK; Duffy A; Gilmore S
J Oncol Pharm Pract; 2016 Apr; 22(2):303-7. PubMed ID: 25567517
[TBL] [Abstract][Full Text] [Related]
16. Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.
Chan JG; Tyne AS; Pang A; McLachlan AJ; Perera V; Chan JC; Britton WJ; Chan HK; Duke CC; Young PM; Traini D
Int J Antimicrob Agents; 2015 Mar; 45(3):319-23. PubMed ID: 25554469
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital.
Cook PP; Gooch M
Int J Antimicrob Agents; 2015 Mar; 45(3):262-7. PubMed ID: 25554468
[TBL] [Abstract][Full Text] [Related]
18. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
[TBL] [Abstract][Full Text] [Related]
19. Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial.
Zhong NS; Sun T; Zhuo C; D'Souza G; Lee SH; Lan NH; Chiang CH; Wilson D; Sun F; Iaconis J; Melnick D
Lancet Infect Dis; 2015 Feb; 15(2):161-71. PubMed ID: 25539586
[TBL] [Abstract][Full Text] [Related]
20. Novel LC-MS/MS method for plasma vancomycin: comparison with immunoassays and clinical impact.
Oyaert M; Peersman N; Kieffer D; Deiteren K; Smits A; Allegaert K; Spriet I; Van Eldere J; Verhaegen J; Vermeersch P; Pauwels S
Clin Chim Acta; 2015 Feb; 441():63-70. PubMed ID: 25523192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
